Literature DB >> 28317136

Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.

Carlo G Artieri1, Carrie Haverty1, Eric A Evans1, James D Goldberg1, Imran S Haque1,2, Yuval Yaron3, Dale Muzzey1.   

Abstract

OBJECTIVE: Performance of noninvasive prenatal screening (NIPS) methodologies when applied to low fetal fraction samples is not well established. The single-nucleotide polymorphism (SNP) method fails samples below a predetermined fetal fraction threshold, whereas some laboratories employing the whole-genome sequencing (WGS) method report aneuploidy calls for all samples. Here, the performance of the two methods was compared to determine which approach actually detects more fetal aneuploidies.
METHODS: Computational models were parameterized with up-to-date published data and used to compare the performance of the two methods at calling common fetal trisomies (T21, T18, T13) at low fetal fractions. Furthermore, clinical experience data were reviewed to determine aneuploidy detection rates based on compliance with recent invasive screening recommendations.
RESULTS: The SNP method's performance is dependent on the origin of the trisomy, and is lowest for the most common trisomies (maternal M1 nondisjunction). Consequently, the SNP method cannot maintain acceptable performance at fetal fractions below ~3%. In contrast, the WGS method maintains high specificity independent of fetal fraction and has >80% sensitivity for trisomies in low fetal fraction samples.
CONCLUSION: The WGS method will detect more aneuploidies below the fetal fraction threshold at which many labs issue a no-call result, avoiding unnecessary invasive procedures.
© 2017 Counsyl Inc. Prenatal Diagnosis published by John Wiley & Sons, Ltd. © 2017 Counsyl Inc. Prenatal Diagnosis published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28317136     DOI: 10.1002/pd.5036

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  15 in total

Review 1.  Current status of spent embryo media research for preimplantation genetic testing.

Authors:  Denice Belandres; Mousa Shamonki; Nabil Arrach
Journal:  J Assist Reprod Genet       Date:  2019-03-21       Impact factor: 3.412

2.  Chromosomal phase improves aneuploidy detection in non-invasive prenatal testing at low fetal DNA fractions.

Authors:  Giulio Genovese; Curtis J Mello; Po-Ru Loh; Robert E Handsaker; Seva Kashin; Christopher W Whelan; Lucy A Bayer-Zwirello; Steven A McCarroll
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

3.  Comment on "Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods".

Authors:  Allison Ryan; Kimberly A Martin
Journal:  Prenat Diagn       Date:  2017-07       Impact factor: 3.050

4.  Using massively parallel shotgun sequencing of maternal plasmatic cell-free DNA for cytomegalovirus DNA detection during pregnancy: a proof of concept study.

Authors:  Virginie Chesnais; Alban Ott; Emmanuel Chaplais; Samuel Gabillard; Diego Pallares; Christelle Vauloup-Fellous; Alexandra Benachi; Jean-Marc Costa; Eric Ginoux
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

5.  Noninvasive paternal exclusion testing for cystic fibrosis in the first five to eight weeks of gestation.

Authors:  David A Zeevi; Fouad Zahdeh; Yehuda Kling; Tzvia Rosen; Paul Renbaum; Raphael Ron-El; Talia Eldar-Geva; Hananel E G Holzer; Ephrat Levy-Lahad; Gheona Altarescu
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

6.  Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.

Authors:  Yuval Yaron; Montse Pauta; Celia Badenas; Anna Soler; Virginia Borobio; Carmen Illanes; Fernanda Paz-Y-Miño; Raigam Martinez-Portilla; Antoni Borrell
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

7.  Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA.

Authors:  Raj Shree; Teodora R Kolarova; Hayley J MacKinnon; Jaclynne M Hedge; Elena Vinopal; Kimberly K Ma; Christina M Lockwood; Suchitra Chandrasekaran
Journal:  Prenat Diagn       Date:  2021-08-14       Impact factor: 3.242

8.  Response to "Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods".

Authors:  Dale Muzzey; Carrie Haverty; Eric A Evans; James D Goldberg
Journal:  Prenat Diagn       Date:  2017-07       Impact factor: 3.050

9.  Clinical experience across the fetal-fraction spectrum of a non-invasive prenatal screening approach with low test-failure rate.

Authors:  S Hancock; R Ben-Shachar; C Adusei; C B Oyolu; E A Evans; H P Kang; C Haverty; D Muzzey
Journal:  Ultrasound Obstet Gynecol       Date:  2020-09       Impact factor: 7.299

10.  Noninvasive prenatal paternity testing by means of SNP-based targeted sequencing.

Authors:  Jacqueline Chor Wing Tam; Yee Man Chan; Shui Ying Tsang; Chung In Yau; Shuk Ying Yeung; Ka Ki Au; Chun Kin Chow
Journal:  Prenat Diagn       Date:  2020-02-20       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.